Discover 3,059 paid clinical trials in Cambridge, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,059
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
for
Brain Metastases, Solid Tumors
Location: Boston MA, New York city NY, Pittsburgh PA
Sponsor: Aposense Ltd.
Sex: All
Age: 18+
Code: NCT00805636
Phase 2, Recruiting
Study of SGR-1505 in Mature B-Cell Neoplasms
for
Mature B-Cell Neoplasm, Non Hodgkin Lymphoma, DLBCL,
Location: Boston MA, Providence RI, The Bronx NY, Hackensack NJ,
Sponsor: Schrödinger, Inc.
Sex: All
Age: 18+
Code: NCT05544019
Phase 1, Recruiting
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Location: Boston MA, Lake Success NY, New York NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06876662
Recruiting
Music Use in Parturients Admitted to Labor & Delivery
for
Anxiety, Pain, Patient Satisfaction
Location: Boston MA
Sponsor: Tufts Medical Center
Sex: Female
Age: 18+
Code: NCT06969105
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Burlington MA, Mount Kisco NY, Colchester VT,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT07082738
Phase 2, Recruiting
Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy
for
Pulmonary Embolism
Location: Boston MA, Providence RI, Portland ME, New York NY,
Sponsor: NYU Langone Health
Sex: All
Age: 18+
Code: NCT05591118
Phase 3, Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
for
Leukemia, Myeloid, Acute
Location: Boston MA, Lebanon NH, The Bronx NY, Hackensack NJ,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06852222
Phase 3, Recruiting
Early Detection of Gestational Diabetes Mellitus in Pregnancy
for
Gestational Diabetes Mellitus in Pregnancy,
Location: Worcester MA
Sponsor: University of Massachusetts, Worcester
Sex: Female
Age: 18+
Code: NCT05388643
Recruiting
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
for
RSV Infection
Location: Boston MA, Norfolk VA, Richmond VA,
Sponsor: Pfizer
Sex: All
Age: 0+
Code: NCT06866405
Phase 3, Recruiting
ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
for
B-cell Acute Lymphoblastic Leukemia,
Location: Boston MA, Buffalo NY, Chicago IL
Sponsor: Marlise Luskin, MD
Sex: All
Age: 18+
Code: NCT03595917
Phase 1, Recruiting
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
for
Crohn's Disease
Location: Boston MA, Harrisburg PA, Richmond VA, Wyoming MI,
Sponsor: Sanofi
Sex: All
Age: 18 - 70+
Code: NCT06958536
Phase 2, Recruiting
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Boston MA, Norwich CT, New Haven CT, Westbury NY,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06943872
Phase 3, Recruiting
A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.
for
Chagas Disease
Location: Boston MA, Gainesville FL, Houston TX, Sylmar CA
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 60
Code: NCT06632600
Phase 2, Recruiting
Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio